{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:07:41Z","timestamp":1760954861213},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.transproceed.2006.02.049","type":"journal-article","created":{"date-parts":[[2006,6,12]],"date-time":"2006-06-12T13:02:30Z","timestamp":1150117350000},"page":"937-942","source":"Crossref","is-referenced-by-count":9,"title":["Recommendations for Use of Everolimus After Heart Transplantation: Results From a Latin-American Consensus Meeting"],"prefix":"10.1016","volume":"38","author":[{"given":"E.A.","family":"Bocchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ahualli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Amuchastegui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Boullon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Cerutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Colque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fiorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Olaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Vulcado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.V.","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2006.02.049_bib1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.healun.2004.05.004","article-title":"The Registry of the International Society for Heart and Lung Transplantation","volume":"23","author":"Taylor","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2006.02.049_bib2","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.healun.2005.01.013","article-title":"From clinical trials to clinical practice","volume":"24","author":"Valantine","year":"2005","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.transproceed.2006.02.049_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.049_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","volume":"24","author":"Eisen","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2006.02.049_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00003495-200464080-00005","article-title":"Everolimus","volume":"64","author":"Chapman","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2006.02.049_bib6","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0041-1345(98)00588-0","article-title":"The in vivo effect of rapamicina dervate SDZ RAD on lymphocyte proliferation","volume":"30","author":"Bohler","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.02.049_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007890-199707150-00007","article-title":"SDZ RAD, a new rapamycin derivate","volume":"64","author":"Schuurnan","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.049_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0966-3274(00)00016-2","article-title":"The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD","volume":"8","author":"Nikolova","year":"2000","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2006.02.049_bib9","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/00007890-200011150-00022","article-title":"Coadministration of the new macrolide immunosuppressive RAD and mycophenolate mofetil in experimental corneal transplantation","volume":"70","author":"Reis","year":"2000","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1016\/j.transproceed.2006.02.049_bib10","first-page":"301","article-title":"FK506 and the rapamycin analogue, SDZ RAD do not have antagonistic effects on lymphocytes from renal transplant patients","volume":"1","author":"Delaney","year":"2001","journal-title":"Am J Transpl"},{"key":"10.1016\/j.transproceed.2006.02.049_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00007890-200002270-00006","article-title":"SDZ-RAD prevents manifestations of chronic rejection in rat renal allografts","volume":"69","author":"Viklicky","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.049_bib12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0041-1345(98)01885-5","article-title":"SDZ RAD inhibits cold ischemic-induced vascular remodeling","volume":"31","author":"Shuurman","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.02.049_bib13","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0041-1345(98)00591-0","article-title":"Effects of rapamycin analogue SDZ RAD on obliterative lesions in a porcine heterotopic bronchial allograft model","volume":"30","author":"Salminen","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.02.049_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1522162802005003006","article-title":"Differential effects of FTY720, RAD, and CsA on signs of chronic rejection in the rat tracheal allograft model","volume":"5","author":"Weckbecker","year":"2002","journal-title":"Graft"},{"key":"10.1016\/j.transproceed.2006.02.049_bib15","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/01.TP.0000090393.75600.32","article-title":"Differential effect of cyclosporin A and SDZ RAD on neointima formation of carotid allograft in apolipoprotein E-deficient mice","volume":"76","author":"Matsumoto","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.049_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1053-2498(99)00118-7","article-title":"Prevention of small airway obliteration in a suine heterotopic lung allograft model","volume":"19","author":"Salminen","year":"2000","journal-title":"J Heart Lung Transplant"},{"issue":"suppl","key":"10.1016\/j.transproceed.2006.02.049_bib17","first-page":"211","article-title":"Longitudinal pharmacokinetics of a everolimus in de novo heart transplantation patients and its influence on cyclosporine","volume":"74","author":"Pirron","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.049_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1592\/phco.22.3.154.33542","article-title":"Effect of food on everolimus absortion","volume":"22","author":"Kovarik","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.transproceed.2006.02.049_bib19","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0041-1345(00)02116-3","article-title":"Comparison of in vivo metabolism of the macrolide immunosuppressants sirolimus and RAD","volume":"33","author":"Jacobsen","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.02.049_bib20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0009-9236(01)15633-X","article-title":"Influence of hepatic impairment on everolimus pharmacokinetics","volume":"70","author":"Kovarik","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2006.02.049_bib21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1034\/j.1600-6143.2003.00107.x","article-title":"Pharmacokinetics of an everolimus-cyplosporine immunosuppressive regimen over the first 6 months after kidney transplantation","volume":"3","author":"Kovarik","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2006.02.049_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2006.02.049_bib23","article-title":"Everolimus in cardiac transplantation 48 months results","author":"Kobashigawa","year":"2005","journal-title":"Am J Transpl"},{"key":"10.1016\/j.transproceed.2006.02.049_bib24","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/j.healun.2005.01.021","article-title":"clinical experience with Certican\u00a9 (Everolimus) in maintenance heart transplant patients at the Medical University of Vienna","volume":"24","author":"Zuckermann","year":"2005","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.transproceed.2006.02.049_bib25","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/01.TP.0000141094.34903.54","article-title":"Everolimus (Certican \u00ae) 12-months safety and efficacy versus mycophenolate mofetil in the novo renal transplant recipients","volume":"78","author":"Vitko","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.049_bib26","first-page":"S206","article-title":"Everolimus (Certican) 12 months safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients","volume":"24","author":"Vitko","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.049_bib27","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1046\/j.1600-6143.2004.00601.x","article-title":"Therapeutic drug monitoring for everolimus in heart transplantation recipients based on exposure-effect modeling","volume":"4","author":"Starling","year":"2004","journal-title":"Am J Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.049_bib28","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.transproceed.2004.09.026","article-title":"Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab","volume":"37","author":"Kramer","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.02.049_bib29","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1600-6143.2005.00975.x","article-title":"Mychophenolate mofetil increased Chagas\u2019 disease reactivation in heart transplanted patients","volume":"5","author":"Bacal","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2006.02.049_bib30","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/0003-4975(96)00141-5","article-title":"Heart transplantation for chronic Chagas\u2019 heart disease","volume":"61","author":"Bocchi","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.transproceed.2006.02.049_bib31","first-page":"1329","article-title":"Long-term follow-up after heart transplantation in Chagas\u2019 disease","volume":"25","author":"Bocchi","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.02.049_bib32","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0003-4975(01)02587-5","article-title":"The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology","volume":"71","author":"Bocchi","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.transproceed.2006.02.049_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1053-2498(00)00235-7","article-title":"The Brazilian experience with heart transplantation","volume":"20","author":"Bocchi","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2006.02.049_bib34","first-page":"325","article-title":"Morbimortalidad de los pacientes con miocardiopatia chag\u00e1sica y transplante card\u0131\u0301aco. Experiencia inicial","volume":"71","author":"Urinovsky","year":"2003","journal-title":"Rev Arg Cardiol"},{"key":"10.1016\/j.transproceed.2006.02.049_bib35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/00912700222011148","article-title":"Pharmacokinetic and pharmacodynamic assessment of HMG-CoA reductase inhibitors when coadministered with Everolimus","volume":"42","author":"Kovarik","year":"2002","journal-title":"J Clin Pharmacology"},{"key":"10.1016\/j.transproceed.2006.02.049_bib36","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1016\/j.healun.2005.01.011","article-title":"Clinical experience with Certican\u00ae (Everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin","volume":"24","author":"Lehmkuhl","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2006.02.049_bib37","first-page":"399","article-title":"Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas\u2019 heart disease","volume":"17","author":"Bocchi","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2006.02.049_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00007691-200504000-00029","article-title":"A new FPIA immunoassay for the quantitative determination of everolimus in whole blood","volume":"27","author":"Boyd","year":"2005","journal-title":"Thera Drug Monit"},{"key":"10.1016\/j.transproceed.2006.02.049_bib39","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/00007890-199912270-00003","article-title":"Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplantation","volume":"68","author":"Cantarovich","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.049_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1053-2498(01)00565-4","article-title":"Monitoring of cyclosporine 2-hr post-dose and trough levels in heart transplantation","volume":"21","author":"Delgado","year":"2002","journal-title":"J Heart Lung Transplant"},{"issue":"suppl","key":"10.1016\/j.transproceed.2006.02.049_bib41","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/j.healun.2004.03.010","article-title":"Optimizing the immunosuppressive regimen in heart transplantation","volume":"23","author":"Eisen","year":"2004","journal-title":"J Heart Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134506001400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134506001400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T16:52:43Z","timestamp":1547571163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134506001400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0041134506001400"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2006.02.049","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}